First Time Loading...

Pfizer Inc
NYSE:PFE

Watchlist Manager
Pfizer Inc Logo
Pfizer Inc
NYSE:PFE
Watchlist
Price: 27.66 USD -1.32% Market Closed
Updated: Jun 13, 2024
Have any thoughts about
Pfizer Inc?
Write Note

Intrinsic Value

Pfizer Inc. is a research-based global biopharmaceutical company. [ Read More ]

The intrinsic value of one PFE stock under the Base Case scenario is 21.81 USD. Compared to the current market price of 27.66 USD, Pfizer Inc is Overvalued by 21%.

Key Points:
PFE Intrinsic Value
Base Case
21.81 USD
Overvaluation 21%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Pfizer Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling PFE stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Pfizer Inc

Current Assets 42.4B
Cash & Short-Term Investments 11.9B
Receivables 15.2B
Other Current Assets 15.3B
Non-Current Assets 178.7B
Long-Term Investments 11.6B
PP&E 18.8B
Intangibles 132.1B
Other Non-Current Assets 16.1B
Current Liabilities 40.5B
Accounts Payable 5.6B
Accrued Liabilities 2.2B
Short-Term Debt 7.2B
Other Current Liabilities 25.5B
Non-Current Liabilities 88.3B
Long-Term Debt 61.3B
Other Non-Current Liabilities 27B
Efficiency

Earnings Waterfall
Pfizer Inc

Revenue
55.1B USD
Cost of Revenue
-16.3B USD
Gross Profit
38.8B USD
Operating Expenses
-28.2B USD
Operating Income
10.6B USD
Other Expenses
-11B USD
Net Income
-309m USD

Free Cash Flow Analysis
Pfizer Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

PFE Profitability Score
Profitability Due Diligence

Pfizer Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Positive Free Cash Flow
Positive Gross Profit
Positive 3-Year Average ROE
Positive Operating Income
59/100
Profitability
Score

Pfizer Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

PFE Solvency Score
Solvency Due Diligence

Pfizer Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
40/100
Solvency
Score

Pfizer Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PFE Price Targets Summary
Pfizer Inc

Wall Street analysts forecast PFE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PFE is 32.09 USD with a low forecast of 27.27 USD and a high forecast of 47.25 USD.

Lowest
Price Target
27.27 USD
1% Downside
Average
Price Target
32.09 USD
16% Upside
Highest
Price Target
47.25 USD
71% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

PFE Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

PFE Price
Pfizer Inc

1M 1M
-3%
6M 6M
+4%
1Y 1Y
-31%
3Y 3Y
-25%
5Y 5Y
-20%
10Y 10Y
+37%
Annual Price Range
27.66
52w Low
25.26
52w High
40.28
Price Metrics
Average Annual Return 12.64%
Standard Deviation of Annual Returns 31.87%
Max Drawdown -57%
Shares Statistics
Market Capitalization 156.7B USD
Shares Outstanding 5 666 590 000
Percentage of Shares Shorted 1.24%

PFE Return Decomposition
Main factors of price return

What is price return decomposition?

PFE News

Other Videos

Last Important Events
Pfizer Inc

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Pfizer Inc

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Pfizer Inc Logo
Pfizer Inc

Country

United States of America

Industry

Pharmaceuticals

Market Cap

156.7B USD

Dividend Yield

5.99%

Description

Pfizer Inc. is a research-based global biopharmaceutical company. The company is headquartered in New York City, New York and currently employs 79,000 full-time employees. The firm is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The firm offers therapeutic candidates in gastroenterology, dermatology, and cardiology, including etrasimod, an oral, selective sphingosine 1-phosphate (S1P) receptor modulator in development for a range of immuno-inflammatory diseases, including ulcerative colitis, Crohn’s Disease, atopic dermatitis, eosinophilic esophagitis, and alopecia areata. The firm works across markets to develop wellness, prevention, treatments and cures. The company collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. The firm's medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness.

Contact

NEW YORK
New York City
235 E 42nd St
+12125732323.0
https://www.pfizer.com/

IPO

1944-01-17

Employees

79 000

Officers

Chairman of the Board & CEO
Dr. Albert Bourla D.V.M., Ph.D.
Chief Financial Officer & Executive VP
Mr. David M. Denton
Chief Scientific Officer and President of Research & Development
Dr. Mikael Dolsten M.D., Ph.D.
Executive VP & General Counsel
Mr. Douglas M. Lankler
Executive VP & Chief U.S. Commercial Officer
Mr. Aamir Malik
Senior VP, Controller & Principal Accounting Officer
Ms. Jennifer B. Damico
Show More
Executive VP and Chief Digital & Technology Officer
Ms. Lidia L. Fonseca
Chief Investor Relations Officer
Ms. Francesca M. DeMartino
Executive VP and Chief Compliance, Quality & Risk Officer
Mr. Rady A. Johnson
Global Chief Marketing Officer
Mr. Andreas J. Panayiotou
Show Less

See Also

Discover More
What is the Intrinsic Value of one PFE stock?

The intrinsic value of one PFE stock under the Base Case scenario is 21.81 USD.

Is PFE stock undervalued or overvalued?

Compared to the current market price of 27.66 USD, Pfizer Inc is Overvalued by 21%.